SCHEMBL5655048

SCHEMBL5655048

O=CCC[N]C(=O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
TDP1 Q9NUW8 4/20 0.43
MAPK1 P28482 3/20 0.43
NR4A2 P43354 1/20 0.41
CES1 P23141 3/20 0.40
MAPT P10636 3/20 0.40
CYP3A4 P08684 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CES2 O00748 2/20 0.39
TSHR P16473 2/20 0.39
DAO P14920 1/20 0.39
NAPRT Q6XQN6 1/20 0.39
GSK3B P49841 2/20 0.38
TRPA1 O75762 1/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4516677 0.78 ALDH1A1 (0.43) ALDH1A1TDP1MAPK1CES1MAPT
SCHEMBL2486789 0.78 CES1 (0.47) ALDH1A1TDP1MAPK1CES1MAPT
SCHEMBL8010207 0.76 GRIN1 (0.52) ALDH1A1TDP1MAPK1KDM4EKMT2A
SCHEMBL3251129 0.74 CES2 (0.50) ALDH1A1CES1SMN1; SMN2CES2LMNA
SCHEMBL10764490 0.74 CES1 (0.46) ALDH1A1TDP1MAPK1NR4A2CES1
SCHEMBL1651044 0.73 CES2 (0.49) ALDH1A1CES1SMN1; SMN2CES2LMNA
SCHEMBL3246383 0.73 CES2 (0.51) ALDH1A1CES1SMN1; SMN2CES2LMNA
SCHEMBL8392233 0.73 NPC1 (0.55) TDP1MAPK1MAPTKMT2ASMN1; SMN2
SCHEMBL9743657 0.72 GSK3B (0.52) ALDH1A1TDP1MAPK1NR4A2CES1
SCHEMBL1387178 0.72 CES1 (0.48) ALDH1A1TDP1MAPK1CES1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070208166-A1 Tao Kinase Modulators And Method Of Use EXELIXIS, INC. (US) 2007-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070208166-A1 Tao Kinase Modulators And Method Of Use TAOK1, TAOK3, MAP3K6 ALDH1A1 4424/4885TDP1 1177/4885MAPK1 265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.